Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03880123
Title Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Matthew Ingham
Indications

sarcoma

alveolar soft part sarcoma

liposarcoma

malignant peripheral nerve sheath tumor

Ewing sarcoma

Therapies

Ixazomib + Selinexor

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.